These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4167669)

  • 1. [Studies on the coagulation effect of mucopolysaccharides from the human aorta].
    Józsa L; Szabó Z; Lusztig G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(3):345-59. PubMed ID: 4167669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of acid mucopolysaccharides from various layers of the arteriosclerotic aortic wall on blood coagulation].
    Lusztig G; Gombás M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(3):292-303. PubMed ID: 4106021
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of antiparacoagulating activity of acid mucopolysaccharides and extracts of the aortic wall.
    Lipiński B
    Thromb Diath Haemorrh; 1969 Nov; 22(2):401-2. PubMed ID: 4245335
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulant properties of three mucopolysaccharides used in rheumatology.
    Bauer F; Schulz P; Reber G; Bouvier CA
    Thromb Haemost; 1983 Oct; 50(3):652-5. PubMed ID: 6228031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in blood coagulation during infusion of intralipid.
    Reid DJ; Ingram GI
    Clin Sci; 1967 Oct; 33(2):399-407. PubMed ID: 6058437
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of acridine dyes on heparin activity and blood coagulation].
    Berge H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):419-25. PubMed ID: 4107578
    [No Abstract]   [Full Text] [Related]  

  • 9. Total glycosaminoglycan fraction from bovine aorta, intestinal mucosa & lungs on the concentration of lipids, plasma lipolytic activity & blood coagulation.
    Sherief PM; Sreekumar P; Sudhakaran PR; Kurup PA
    Indian J Exp Biol; 1978 Feb; 16(2):218-21. PubMed ID: 680816
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation Inhibitor Potential: a study of assay variables.
    Andresen MS; Abildgaard U
    Thromb Res; 2005; 115(6):519-26. PubMed ID: 15792684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the adhesiveness of thrombocytes under the effect of anticoagulants].
    Merkulov MF; Lakin KM; Fel'dbaum VA; Efimov VS
    Farmakol Toksikol; 1968; 31(6):706-9. PubMed ID: 5713582
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects on the coagulation-fibrinolysis system of a single oral dose of mesoglycan at the beginning and at the end of a prolonged treatment in man].
    Blardi P; Messa G; Puccetti L; La Placa G; Ghezzi A
    Recenti Prog Med; 1995; 86(7-8):282-9. PubMed ID: 7569284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the blood coagulation and anticoagulation system against a background of narcosis and ganglionic block].
    Seit-Umerov SM; Poliukhov SM; Obydennikova TN
    Vestn Khir Im I I Grek; 1969 Aug; 103(8):16-9. PubMed ID: 4394393
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of the effect of immobilized noradrenaline on the contact phase of blood coagulation].
    Zubairov DM; Popova LG; Krinskaia AV; Egorova TP; Fedorova NV
    Vopr Med Khim; 1979; 25(5):544-8. PubMed ID: 494537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thrombus formation by arterial and venous mucopolysaccharides.
    Izuka K; Murata K; Nakazawa K
    Z Alternsforsch; 1973; 27(3):263-8. PubMed ID: 4272396
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Heparin thrombin clotting-time and platelet factor 4.
    O'Brien JR; Etherington M; Jamieson S; Lawford P
    Lancet; 1974 Sep; 2(7881):656-7. PubMed ID: 4137779
    [No Abstract]   [Full Text] [Related]  

  • 18. [Control of coagulation in extracorporeal circulation. Importance of the routine use of activated blood coagulation time].
    Evora PR; Brasil JC; Otaviano AG; Margarido EA; Ribeiro PJ; Reis CL; Silva JR; Secches AL
    Arq Bras Cardiol; 1981 Aug; 37(2):89-93. PubMed ID: 7348180
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood coagulation and excretion of coagulation and fibrinolysis factors with urine of patients with diffuse glomerulonephritis].
    Zorina SS; Krasik IaD
    Ter Arkh; 1974; 46(7):54-62. PubMed ID: 4408677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.